Recent Quotes
My Watchlist
Indicators
Investor Uprising 25
Markets:
Overview
News
Currencies
International
Treasuries

Metagenomi, Inc. - Common Stock (NQ:MGX)

2.440 +0.090 (+3.83%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Metagenomi, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Metagenomi Inc (NASDAQ:MGX) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected
Metagenomi Inc (NASDAQ:MGX) reported Q2 2025 earnings with revenue beating estimates at $8.51M and a narrower loss of -$0.54 per share. Shares dipped slightly amid investor caution over cash burn and... 
Via Chartmill
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors
Dr. Reid brings 30 years of experience in building biotech companies based on innovative scientific platforms and shaping pipeline and business strategy 
From Metagenomi, Inc.
Via GlobeNewswire
Expert Outlook: Metagenomi Through The Eyes Of 4 Analysts
 
Via Benzinga
Which stocks are gapping on Wednesday?
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
Sam Altman Says He 'Didn't Think' Elon Musk Would Abuse Government Power, Tesla CEO Hits Back With 'Scam Altman' Jibe
OpenAI CEO Sam Altman regrets underestimating Elon Musk's potential abuse of power to block OpenAI's $500B Stargate deal. Tensions also rise with Microsoft. 
Via Benzinga
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
Lilly's Verve acquisition lifts sentiment in gene editing stocks, with analysts calling it a strategic and timely move in a tough funding climate. 
Via Benzinga
Demystifying Metagenomi: Insights From 4 Analyst Reviews
 
Via Benzinga
Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi to Present at Upcoming Scientific Meetings
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi Reports Business Updates and Full Year 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week
Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025. 
Via Stocktwits
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference
From Metagenomi, Inc.
Via GlobeNewswire
Stargate, Netflix, GE Aerospace, Twilio, and More
There's a lot for investors to talk about. 
Via The Motley Fool
Trump’s “Stargate AI” Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO
Via AB Newswire
Topics Artificial Intelligence Government
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi Announces New Appointment to its Board of Directors
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting
From Metagenomi, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi
From Faruqi & Faruqi, LLP
Via Business Wire
MGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)
From The Law Offices of Frank R. Cruz
Via Business Wire
DEADLINE NEXT WEEK: Berger Montague Advises Metagenomi (NASDAQ: MGX) Investors to Contact the Firm Before November 25, 2024
From Berger Montague
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.